Mast cells in innate immunity

Immunological Reviews

Volumn 173, Issue , 2000, Pages 131-140

  Mekori, Yoseph A ^a,b   Metcalfe, Dean D ^c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; BACTERIAL INFECTION; CYTOKINE PRODUCTION; HOST RESISTANCE; IMMUNITY; INFLAMMATION; LEUKOCYTE ACTIVATION; MAST CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNITY, NATURAL; IMMUNOGLOBULIN E; INFLAMMATION; MAST CELLS; MICE; MODELS, IMMUNOLOGICAL; PHAGOCYTES;

EID: 0033965301     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.917305.x     Document Type: Review

References (80)

1. 1. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-1079.
2. 2. Galli SJ. Complexity and redundancy in the pathogenesis of asthma: reassessing the role of mast cells and T cells. J Exp Med 1997;186:343-347.
3. 3. Nilsson G, Costa JJ, Metcalfe DD. Mast cells and basophils. In: Gallin JI, Snyderman R, eds. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott & Wilkins; 1999. p. 97-117.
4. 4. Mekori YA, Oh CK, Metcalfe DD. IL-3 dependent mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 1993;151:3775-3784.
5. + bone marrow progenitor cells. J Immunol 1991;146:1410-1415.
6. 6. Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 1996;271:818-822.
7. +, and express aminopeptidase N (CD13). Blood 1999;94:1-11.
8. + pluripotent progenitor cells. J Immunol 1992;148:772-777.
9. 9. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994;55:1-96.
10. 10. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns M. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999;96:8080-8085.
11. 11. Nilsson G, Schwartz LB. Mast cell heterogeneity: structure and mediators. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Boston: Blackwell Science; 1995. p. 195-208.
12. 12. Ramos BF, Qureshi R, Olsen KM, Jakschik BA. The importance of mast cells for the neutrophil influx in immune complex-induced peritonitis in mice. J Immunol 1990;145:1868-1873.
13. 13. Sylvestre DL, Ravetch JV. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 1996;5:387-390.
14. 14. Nutman TB. Mast cells and their role in parasitic infection. In: Metcalfe DD, Kaliner MA, eds. The mast cell in health and disease. New York: Marcel Dekker; 1993. p. 669-686.
15. 15. Alber G, Kent UM, Metzger H. Functional comparison of FcεRI, FcγRII and FcγRIII in mast cells. J Immunol 1992;149:2428-2436.
16. 16. Galli SJ, Lantz CS. Allergy. In: Paul WE, ed. Fundamental immunology. Philadelphia: Lippincott-Raven Press; 1999. p. 1137-1184.
17. 17. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 1991;3:865-872.
18. 18. Columbo M, Horowitz EM, Kagey Sobotka A, Lichtenstein LM. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopathol 1996;81:68-73.
19. 19. Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-α gene expression in murine mast cells. J Immunol 1993;150:4478-4485.
20. 20. Yamamura H, Nabe T, Kohno S, Ohata K. Endothelin 1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur J Pharmacol 1994;265:9-15.
21. 21. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med 1992;176:781-786.
22. 22. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994;152:1298-1303.
23. 23. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a and C5a-induced mediator release from dissociated human skin mast cells. J Invest Deramatol 1994;102:803-816.
24. 24. Wojecka-Lukasik E, Maslinski S. Fibronectin and fibrinogen degradation products stimulate PMN leukocyte and mast cell degranulation. J Physiol Pharmacol 1992;43:173-181.
25. 25. Machado DC, Horton D, Harrop R, Peachell PT, Helm BA. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen specific IgE. Eur J Immunol 1996;26:2972-2980.
26. 26. Inamura N, Mekori YA, Bhattacharyya SP, Bianchine PJ, Metcalfe DD. Induction and enhancement of FcεRI-dependent mast cell degranulation following co-culture with activated T cells. J Immunol 1998;160:4026-4033.
27. 27. Mekori YA, Metcalfe DD. Mast cell-T cell interactions. J Allergy Clin Immunol 1999;104:517-523.
28. 28. Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999;11:53-59.
29. 29. Abraham SN, Arock M. Mast cell and basophils in innate immunity. Semin Immunol 1998;10:373-381.
30. 30. Sher A, Hein A, Moser G, Caulfield JP. Complement receptors promote the phagocytosis of bacteria by rat peritoneal mast cells. Lab Invest 1979;41:490-499.
31. 31. Sher A. Complement-dependent adherence of mast cells to schistosomula. Nature 1976;263:334-336.
32. 32. Malaviya R, et al. Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994;152:1907-1914.
33. 33. Arock M, Ross E, Lai-Kuen R, Averlant G, Gao Z, Abraham S. Phagocytic and tumor necrosis factor α response of human mast cells following exposure to gram negative and gram positive bacteria. Infect Immun 1998;66:6030-6034.
34. 34. Bidri M, et al. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol 1997;19:475-483.
35. 35. Milaviya R, Ross E, Jakschik BA, Abraham SN. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest 1994;93:1645-1653.
36. 36. Malaviya R, Gao Z, Thankavel K, van de Merwe A, Abraham SN. The mast cell tumor necrosis factor a response to FimH-expressing E. coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999;96:8110-8115.
37. 37. Komisar J, Rivera J, Vega A, Tseng J. Effects of staphylococcal enterotoxin B on rodent mast cells. Infect Immun 1992;60:2969-2975.
38. 38. Calderon GM, et al. Effects of toxin from Clostridium difficile on mast cell activation and survival. Infect Immun 1998;66:2755-2761.
39. 39. Leal-Berumen I, Snider DP, Barajas-Lopez C, Marshall JS. Cholera toxin increases IL-6 synthesis and decreases TNF-α production by rat peritoneal mast cells. J Immunol 1996;156:316-321.
40. 40. Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol 1994;152:5468-5476.
41. 41. Mezhitov R, Janeway CA. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997;9:4-9.
42. 42. Nechushtan H, Razin E. Regulation of mast cell growth and proliferation. Crit Rev Oncol Hematol 1996;23:131-150.
43. 43. Falus A, Meretey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 1992;13:154-156.
44. 44. Slauson DO, Walker C, Kristensen F, Wang W, DeWeck AL. Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell Immunol 1984;84:240-246.
45. 2-induced inhibition of interleukin 2 production. J Immunol 1983;130:1770-1773.
46. 46. Lider O, et al. Inhibition of T lymphocyte heparanase by heparin prevents cell migration and T cell mediated immunity. Eur J Immunol 1990;20:493-499.
47. 47. Baram D, Rashkovsky M, Hershkoviz R, Drucker I, Reshef T, Mekori YA. Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clin Exp Immunol 1997;110:485-491.
48. 48. Gauchat JF, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993;365:430-343.
49. 49. Mecheri S, David D. Unraveling the mast cell dilemma: culprit or victim of its generosity? Immunol Today 1997;18:212-215.
50. 50. Gaboury JP, Johnson B, Niu XF, Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 1995;154:804-813.
51. 51. Kubes P, Kanwar S. Histamine induces leukocyte rolling on post-capillary venules. A P-selectin-mediated event. J Immunol 1994;152:3570-3577.
52. 52. Wershil BK, Furuta GT, Wang ZS, Galli SJ. Mast cell dependent neutrophil and mononuclear cell recruitment in IgE-induced gastric reactions in mice. Gastroemerology 1996;110:1482-1490.
53. 53. Qureshi R, Jakschik BA. The role of mast cells in thioglycollate-induced inflammation. J Immunol 1988;141:2090-2096.
54. 54. Wershil BK, Murakami I, Galli SJ. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. J Immunol 1988;140:2356-2360.
55. 55. Malaviya R, Ikeda T Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-80.
56. 56. Echtenbacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77.
57. 57. Wershil BK, Wang ZS, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-mediated cutaneous late phase responses in the mouse is mast cell dependent. J Clin Invest 1991;87:446-452.
58. 58. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4224.
59. 59. Meng H, Tonnesen MG, Marchese MJ, Clark RAF, Bahou WF, Gruber BL. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J Cell Physiol 1995;165:40-53.
60. 60. Wegner CD, Gundel RH, Reilly PJ, Hynes N, Gordon LR. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
61. 61. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Immunol 1995;154:799-803.
62. 62. Moller A, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-3266.
63. 63. Compton SJ, Cairns JA, Holgate ST, Walls AF. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release and adhesion molecule expression. J Immunol 1998;161:1939-1946.
64. + T lymphocyte chemoattractant factor, IL-16. J Immunol 1997;159:2904-2910.
65. 65. Miller HR, Newlands GF, McKellar A, Inglis L, Coulson PS, Wilson RA. Hepatic recruitment of mast cells occurs in rats but not in mice infected with Schistosoma mansoni. Parasite Immunol 1994;16:145-155.
66. 66. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 1996;156:1490-1496.
67. 2. J Immunol 1995;155:2605-2613.
68. 68. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-54.
69. 69. Mekori YA, Weitzman GL, Galli SJ. Re-evaluation of reserpine-induced suppression of contact sensitivity. J Exp Med 1985;162:1935-1953.
70. 70. Galli SJ, Wershil BK. The two faces of the mast cell. Nature 1996;381:21-22.
71. 71. Maurer M, et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998;188:2343-2348.
72. 72. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992;258:1957-1959.
73. 73. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1998;162:1685-1691.
74. 74. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll M. Impaired mast cell-dependent natural immunity in C3-deficient mice. Nature 1997;390:172-175.
75. 75. Rosenkranz AR, et al. Impaired mast cell development and innate immunity in Mac-1 (CD1 1b/CD18, CR3)-deficient mice. J Immunol 1998;161:6463-6467.
76. 76. Kusugai T, et al. Infection with Nippostrongylus brasiliensis induces invasion of mast cell precursors from peripheral blood to small intestine. Blood 1995;85:1334-1340.
77. 77. Svetic A, et al. A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol 1993;150:3434-3441.
78. 78. Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell mediated toxicity to schistosomula of Schistosoma mansoni: potentiation by exogenous peroxidase. J Immunol 1986;137:2695-2699.
79. 79. Harari Y, Russel DA, Castro GA. Anaphylaxis-mediated epithelial C1-secretion and parasite rejection in rat intestine. J Immunol 1987;138:1250-1255.
80. 80. Barrett KE. Immune-related intestinal chloride secretion. III. Acute and chronic effects of mast cell mediators on chloride secretion by a human colonie epithelial cell line. J Immunol 1991;147:959-964.